Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy

Yucai Wang, Melissa C. Larson, Steven R. Hwang, Anita Kumar, Ashlee Joseph, Brian T. Hill, Taylor R. Brooks, David A. Bond, Kami J. Maddocks, Alexey Danilov, Christine McCarthy, Jia Ruan, Imran A. Nizamuddin, Brad S. Kahl, Natalie S. Grover, Nazneen B. Khan, Evguenia Ouchveridze, Aung M. Tun, Philip Young, Craig A. Portell, Zoey I. Harris, Javier L. Munoz, Patrick M. Reagan, Georgio Pongas, Izidore S. Lossos, Christine E. Ryan, Reid W. Merryman, Firas Baidoun, Muhamad Alhaj Moustafa, Drew Gerber, Sabarish R. Ayyappan, Brian K. Link, Arash Velayati, Irl Brian Greenwell, Lauren G Banaszak, Priyanka A Pophali, Anthony C. Stack, Marcus R. Messmer, Mayur Narkhede, Amitkumar N. Mehta, Preetesh Jain, Michael L. Wang, Tamara K. Moyo, Nilanjan Ghosh, Rahul S. Bhansali, Stefan K. Barta, Manali K. Kamdar, Jacob Anna, Alexander V. Stanisic, Reem Karmali, Laveniya Kugathasan, Diego Villa, Matthew J. Maurer, James R. Cerhan, Jonathon B. Cohen, Peter Martin

Blood (2023) 142 (Supplement 1): 300.

https://doi.org/10.1182/blood-2023-182942

Published: 2023

Journal Articles

Frequency and Outcomes of Obinutuzumab-Induced Thrombocytopenia

Jun Yen Ng, Maansi Joshi, Philip Young-Ill Choi

Blood (2023) 142 (Supplement 1): 3967.

https://doi.org/10.1182/blood-2023-178135

Published: 2023

Journal Articles

Platelet Dysfunction Detected Using Rotational Thromboelastometry (ROTEM) in Severely Thrombocytopenic Patients with a Bleeding Phenotype

Philip Young-Ill Choi, BSc, MBBS, PhD, Sarah Hicks, Elizabeth E. Gardiner, PhD, Philip Crispin, MBBS, FRACP, FRCPA, James Slade, BN, GCCaN, MNNP, James D'Rozario, MBBS, FRACP, FRCPA, Christopher Parish, PhD, Lucy Coupland, PhDBSc,RN

Blood (2019) 134 (Supplement_1): 2357.

https://doi.org/10.1182/blood-2019-132232

Published: 2019

Journal Articles

Nucleic Acids Interfere with PF4 Tetramer Formation and Stabilise PF4 Monomers to Bind Non-Pathogenic HIT Antibodies: Subtypes of Non-Pathogenic Antibodies Emerge

Philip Young-Ill Choi, BSc, MBBS, PhD, Kumiko Tanaka, PhD, Jose Perdomo, PhD, Beng H Chong, MBBS, PhD

Blood (2018) 132 (Supplement 1): 2439.

https://doi.org/10.1182/blood-2018-99-117826

Published: 2018

Journal Articles

Successful Treatment of Alemtuzumab Induced Immune Thrombocytopenia with a Thrombopoietin Receptor Agonist

Fathima Mohiyaddin Ayyalil, MBBS, James Slade, BN, GCCaN, MNNP, Daniel Wang, MBBS, James M. D'Rozario, MBBS FRACP FRCPA, Stephen Reddel, MBBS, FRACP, PhD, Philip Young-Ill Choi, BA, BSc, MBBS, PhD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 2326.

https://doi.org/10.1182/blood.V130.Suppl_1.2326.2326

Published: 2017

Journal Articles

Non-Pathogenic Antibodies in HIT: Clustering for Clarity

Philip Young-Ill Choi, MBBS FRCPA FRACP

Blood (2015) 126 (23): 3481.

https://doi.org/10.1182/blood.V126.23.3481.3481

Published: 2015

Journal Articles

A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)

Philip Young-Ill Choi, Fernando Roncolato, Xavier Badoux, Sundra Ramanathan, Shir-Jing Ho, Beng H. Chong

Blood (2015) 126 (4): 500–503.

https://doi.org/10.1182/blood-2015-03-631937

Published: 2015

Includes: Supplemental data

Journal Articles

Serum Free Light Chain Levels Post Allogeneic Stem Cell Transplantation Are Associated With Improved Overall Survival In Patients With Acute Myeloid Leukemia

Sophie Lee, Philip Young, Joanne Croudace, Ben Abbotts, Ladan Adie, Jane Nunnick, Ram Malladi, Guy Pratt, Charles Craddock, Stephen Harding, Paul Moss

Blood (2013) 122 (21): 4621.

https://doi.org/10.1182/blood.V122.21.4621.4621

Published: 2013

Journal Articles

Isotype Matched Paired Immunoglobulin Suppression Identifies High Risk Multiple Myeloma Patients and Is Independent Of Bone Marrow Infiltration Suggesting Significant Variability In The HLC Matched Pair Suppressive Activity Of Individual Myeloma Clones

Heinz Ludwig, MD, Dejan Milosavljevic, Philip Young, Niklas Zojer, Stephen Harding

Blood (2013) 122 (21): 5352.

https://doi.org/10.1182/blood.V122.21.5352.5352

Published: 2013

Journal Articles

Triple Therapy For Immune Thrombocytopenia: A Novel Combination Of Conventional Strategies To Safely Sustain Platelet Counts In ITP

Philip Young-Ill Choi, BA BSc(Med) MBBS FRACP FRCPA, Soo-Chin Ng, FRCP, FRCPA, Christine Lee, MD, Fernando Roncolato, MBBS FRCPA FRACP, Xavier Badoux, MBBS FRACP FRCPA, Amanda J. Hugman, MBBS FRCPA FRACP, Sundra Ramanathan, MBBS (Hons) FRACP FRCPA, Shir-Jing Ho, MBBS, FRACP, FRCPA, Szu-Hee Lee, MBBChir, PhD, FRCPA, FRACP, Beng Chong, MBBS FRCPA FRACP PhD

Blood (2013) 122 (21): 1084.

https://doi.org/10.1182/blood.V122.21.1084.1084

Published: 2013

Journal Articles

Intact Immunoglobulin or Fragments Thereof Can Be Detected in Urine in a Proportion of Patients with Multiple Myeloma and Are Associated with Reduced Survival At Presentation

Heinz Ludwig, Philip Young, Dejan Milosavljevic, Niklas Zojer, Wolfgang Hübl, Stephen Harding

Blood (2012) 120 (21): 1828.

https://doi.org/10.1182/blood.V120.21.1828.1828

Published: 2012

Journal Articles

Immunoglobulin Heavy/Light Chain Measurements During Monitoring Provide Prognostic Information of Relapse After Therapy in Myeloma Patients

Mark T Drayson, MD, Oscar Berlanga, Tim Plant, Nicola J Newnham, Philip Young, Stephen Harding, PhD

Blood (2012) 120 (21): 3964.

https://doi.org/10.1182/blood.V120.21.3964.3964

Published: 2012

Journal Articles

IgA Hevylite® Test As a Surrogate to Serum Protein Electrophoresis (SPEP) or Nephelometry in the Management of IgA Myeloma

Eileen Mary Boyle, MD, Philip Young, Helene Demarquette, MD, Julie Gay, MD, Houria Debarri, MD, Sarah Bonnet, MD, Charles Herbaux, MD, Remy Dulery, MD, Salomon Manier, MD, Jean-Luc Faucompre, Frederic Combat, MD, Annie Pietrantuono, MD, Brigitte Onraed, Bernadette Hennache, Thierry Facon, MD, Stephen J Harding, MD, PhD, Xavier Leleu, MD, PhD

Blood (2012) 120 (21): 3970.

https://doi.org/10.1182/blood.V120.21.3970.3970

Published: 2012

Journal Articles

Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM)

Heinz Ludwig, MD, Jeffrey Faint, Niklas Zojer, Arthur R Bradwell, Philip Young, Dejan Milosavljevic, Wolfgang Hübl, Stephen Harding

Blood (2011) 118 (21): 2883.

https://doi.org/10.1182/blood.V118.21.2883.2883

Published: 2011

Journal Articles

The Mortality of Vancomycin-Resistant Enterococci Bloodstream Infections (VRE BSI)

Philip Young-Ill Choi, BA BSc(Med) MBBS FRACP FRCPA, Belinda Straube, RN, Christine Cook, RN, Carrie Van Der Weyden, MBBS, Sundra Ramanathan, MBBS (Hons) FRACP FRCPA, Peter Taylor, MBBS FRCPA, Fernando Roncolato, FRCPA, FRACP, Beng Chong, MBBS, PhD

Blood (2011) 118 (21): 4928.

https://doi.org/10.1182/blood.V118.21.4928.4928

Published: 2011

NARROW

Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy

Frequency and Outcomes of Obinutuzumab-Induced Thrombocytopenia

Platelet Dysfunction Detected Using Rotational Thromboelastometry (ROTEM) in Severely Thrombocytopenic Patients with a Bleeding Phenotype

Nucleic Acids Interfere with PF4 Tetramer Formation and Stabilise PF4 Monomers to Bind Non-Pathogenic HIT Antibodies: Subtypes of Non-Pathogenic Antibodies Emerge

Successful Treatment of Alemtuzumab Induced Immune Thrombocytopenia with a Thrombopoietin Receptor Agonist

Non-Pathogenic Antibodies in HIT: Clustering for Clarity

A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)

Serum Free Light Chain Levels Post Allogeneic Stem Cell Transplantation Are Associated With Improved Overall Survival In Patients With Acute Myeloid Leukemia

Isotype Matched Paired Immunoglobulin Suppression Identifies High Risk Multiple Myeloma Patients and Is Independent Of Bone Marrow Infiltration Suggesting Significant Variability In The HLC Matched Pair Suppressive Activity Of Individual Myeloma Clones

Triple Therapy For Immune Thrombocytopenia: A Novel Combination Of Conventional Strategies To Safely Sustain Platelet Counts In ITP

Intact Immunoglobulin or Fragments Thereof Can Be Detected in Urine in a Proportion of Patients with Multiple Myeloma and Are Associated with Reduced Survival At Presentation

Immunoglobulin Heavy/Light Chain Measurements During Monitoring Provide Prognostic Information of Relapse After Therapy in Myeloma Patients

IgA Hevylite® Test As a Surrogate to Serum Protein Electrophoresis (SPEP) or Nephelometry in the Management of IgA Myeloma

Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM)

The Mortality of Vancomycin-Resistant Enterococci Bloodstream Infections (VRE BSI)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only